Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase

被引:41
|
作者
Maynard, Andrew [2 ]
Crosby, Renae M. [1 ]
Ellis, Byron [2 ]
Hamatake, Robert [1 ]
Hong, Zhi [1 ]
Johns, Brian A. [1 ]
Kahler, Kirsten M. [2 ]
Koble, Cecilia [1 ]
Leivers, Anna [1 ]
Leivers, Martin R. [1 ]
Mathis, Amanda [1 ]
Peat, Andrew J. [1 ]
Pouliot, Jeffrey J. [1 ]
Roberts, Christopher D. [1 ]
Samano, Vicente [1 ]
Schmidt, Rachel M. [2 ]
Smith, Gary K. [2 ]
Spaltenstein, Andrew [1 ]
Stewart, Eugene L. [2 ]
Thommes, Pia [3 ]
Turner, Elizabeth M. [1 ]
Voitenleitner, Christian [1 ]
Walker, Jill T. [1 ]
Waitt, Greg [2 ]
Weatherhead, Jason [1 ]
Weaver, Kurt [2 ]
Williams, Shawn [2 ]
Wright, Lois [2 ]
Xiong, Zhiping Z. [1 ]
Haigh, David [3 ]
Shotwell, J. Brad [1 ]
机构
[1] GlaxoSmithKline, Infect Dis Med Discovery Unit, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Platform Technol & Sci, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Infect Dis Ctr Excellence Drug Discovery, Stevenage SG1 1NY, Herts, England
关键词
HEPATITIS-C VIRUS; NONNUCLEOSIDE INHIBITORS; ANTIFUNGAL AGENT; RESISTANCE; MECHANISMS; NUCLEOTIDE; INITIATION; PROTEASE; SITE;
D O I
10.1021/jm400317w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A boronic acid moiety was found to be a critical pharmacophore for enhanced in vitro potency against wild-type hepatitis C replicons and known clinical polymorphic and resistant HCV mutant replicons. The synthesis, optimization, and structure-activity relationships associated with inhibition of HCV replication in a subgenomic replication system for a series of non-nucleoside boron-containing HCV RNA-dependent RNA polymerase (NS5B) inhibitors are described. A summary of the discovery of 3 (GSK5852), a molecule which entered clinical trials in subjects infected with HCV in 2011, is included.
引用
收藏
页码:1902 / 1913
页数:12
相关论文
共 50 条
  • [1] DISCOVERY OF A NOVEL, POTENT FLAVONOID INHIBITOR OF HCV RNA-DEPENDENT RNA POLYMERASE
    Ahmed-Belkacem, A.
    Brillet, R.
    Pallier, C.
    Wychowski, C.
    Guichou, J. -F.
    Pawlotsky, J. -M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S288 - S288
  • [2] Resistance to mericitabine, a nucleoside analogue inhibitor of HCV RNA-dependent RNA polymerase
    Pawlotsky, Jean-Michel
    Najera, Isabel
    Jacobson, Ira
    ANTIVIRAL THERAPY, 2012, 17 (03) : 411 - 423
  • [3] HCV RNA-dependent RNA polymerase as a target for antiviral development
    Walker, MP
    Hong, Z
    CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (05) : 534 - 540
  • [4] Thumb II Site Inhibitor Allosterically Suppresses the Dynamics of HCV RNA-Dependent RNA Polymerase
    Deredge, Daniel J.
    Johnson, Kenneth
    Wintrode, Patrick
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 529A - 529A
  • [5] Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro
    Lu, Liangjun
    Dekhtyar, Tatyana
    Masse, Sherie
    Pithawalla, Ron
    Krishnan, Preethi
    He, Wenping
    Ng, Teresa
    Koev, Gennadiy
    Stewart, Kent
    Larson, Dan
    Bosse, Todd
    Wagner, Rolf
    Pilot-Matias, Tami
    Mo, Hongmei
    Molla, Akhteruzurnman
    ANTIVIRAL RESEARCH, 2007, 76 (01) : 93 - 97
  • [6] De novo RNA synthesis catalyzed by HCV RNA-dependent RNA polymerase
    Sun, XL
    Johnson, RB
    Hockman, MA
    Wang, QM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 268 (03) : 798 - 803
  • [7] FLAVONOIDS, A NOVEL CLASS OF HCV RNA-DEPENDENT RNA POLYMERASE INHIBITORS
    Ahmed-Belkacem, Abdelhakim
    Brillet, Rozenn
    Pallier, Coralie
    Wychowski, Czeslaw
    Guichou, Jean-Francois
    Pawlotsky, Jean-Michel
    HEPATOLOGY, 2009, 50 (04) : 1043A - 1043A
  • [8] Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses
    Kumar, Rahul
    Mishra, Sahil
    Shreya
    Maurya, Sushil K.
    RSC MEDICINAL CHEMISTRY, 2021, 12 (03): : 306 - 320
  • [9] Discovery of a potent inhibitor targeting the cap-binding domain of the PB2 subunit of influenza RNA-dependent RNA polymerase
    Sun, Weining
    Zhang, Ziling
    Chen, Mingxin
    Liu, Xinlei
    Wang, Yifei
    Yao, Shaohua
    Li, Linli
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 678 : 97 - 101
  • [10] BIOCHEMICAL CHARACTERIZATION OF GL60667 (LDI133), A POTENT NON-NUCLEOSIDE INHIBITOR OF THE HCV RNA-DEPENDENT RNA POLYMERASE
    Pouliot, Jeffrey
    Pagila, Rene N.
    Fung, Kevin
    Deng, Gejing
    Chenail, Gregg
    Latour, Derek R.
    Zhang, John
    Koo-McCoy, Samantha
    Sivaraja, Mohanram
    Bechtel, Jill
    Lin, Kai
    Gralapp, Joshua
    Alvarez, Salvador G.
    Leivers, Martin
    Schmitz, Uli
    Compton, Teresa
    Griffith, Ronald
    HEPATOLOGY, 2008, 48 (04) : 1165A - 1166A